Document is current

Any future updates will be listed below

Correction: Population Pharmacokinetics Analysis of Infliximab in up to 10‑Year‑Old Patients with Paediatric Inflammatory Bowel Disease: Label‑Recommended Dose Fails to Achieve Therapeutic Target Concentration

Crossref DOI link: https://doi.org/10.1007/s40262-025-01599-w

Published Online: 2025-11-28

Published Print: 2026-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark